Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Moroni

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
American Journal of Clinical Oncology|April 2, 2004
On the need of biopsy confirmation at suspected first recurrence of cancerLuigi Cavanna, Daniele Vallisa, Antonio Lazzaro, et al.
British Journal of Pharmacology|September 23, 2008
Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell deathL Formentini, P Arapistas, M Pittelli, et al.
Journal of Medicinal Chemistry|September 15, 1995
1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptorsR Pellicciari, R Luneia, G Costantino, et al.
Cell Death and Differentiation|August 30, 2001
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemiaF Moroni, E Meli, F Peruginelli, et al.
Journal of Medicinal Chemistry|March 4, 1994
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylaseR Pellicciari, B Natalini, G Costantino, et al.
Neurobiology of Disease|June 24, 2014
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptorsE Gerace, A Masi, F Resta, et al.
Cancer|June 15, 1994
Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II studyB Neri, C Fiorelli, F Moroni, et al.
Journal of Viral Hepatitis|July 18, 2006
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patientsA Cozzi, A L Zignego, R Carpendo, et al.
European Journal of Pharmacology|July 21, 1992
Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidationF Moroni, M Alesiani, L Facci, et al.
Hepatology (Baltimore, Md.)|September 1, 1987
Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluidF Moroni, O Riggio, V Carlà, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
American Journal of Clinical Oncology|April 2, 2004
On the need of biopsy confirmation at suspected first recurrence of cancerLuigi Cavanna, Daniele Vallisa, Antonio Lazzaro, et al.
British Journal of Pharmacology|September 23, 2008
Mono-galloyl glucose derivatives are potent poly(ADP-ribose) glycohydrolase (PARG) inhibitors and partially reduce PARP-1-dependent cell deathL Formentini, P Arapistas, M Pittelli, et al.
Journal of Medicinal Chemistry|September 15, 1995
1-Aminoindan-1,5-dicarboxylic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptorsR Pellicciari, R Luneia, G Costantino, et al.
Cell Death and Differentiation|August 30, 2001
Poly(ADP-ribose) polymerase inhibitors attenuate necrotic but not apoptotic neuronal death in experimental models of cerebral ischemiaF Moroni, E Meli, F Peruginelli, et al.
Journal of Medicinal Chemistry|March 4, 1994
Modulation of the kynurenine pathway in search for new neuroprotective agents. Synthesis and preliminary evaluation of (m-nitrobenzoyl)alanine, a potent inhibitor of kynurenine-3-hydroxylaseR Pellicciari, B Natalini, G Costantino, et al.
Neurobiology of Disease|June 24, 2014
PARP-1 activation causes neuronal death in the hippocampal CA1 region by increasing the expression of Ca(2+)-permeable AMPA receptorsE Gerace, A Masi, F Resta, et al.
Cancer|June 15, 1994
Modulation of human lymphoblastoid interferon activity by melatonin in metastatic renal cell carcinoma. A phase II studyB Neri, C Fiorelli, F Moroni, et al.
Journal of Viral Hepatitis|July 18, 2006
Low serum tryptophan levels, reduced macrophage IDO activity and high frequency of psychopathology in HCV patientsA Cozzi, A L Zignego, R Carpendo, et al.
European Journal of Pharmacology|July 21, 1992
Thiokynurenates prevent excitotoxic neuronal death in vitro and in vivo by acting as glycine antagonists and as inhibitors of lipid peroxidationF Moroni, M Alesiani, L Facci, et al.
Hepatology (Baltimore, Md.)|September 1, 1987
Hepatic encephalopathy: lack of changes of gamma-aminobutyric acid content in plasma and cerebrospinal fluidF Moroni, O Riggio, V Carlà, et al.
Pageof 25